Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermat... (ta Incorporated Tara Spiess TS Com...)

(Date:12/16/2009)... -- DATATRAK International, Inc. (OTCQX: DATA), a ... eClinical solutions for the clinical trials industry, ... 9.0 eClinical Software. This release advances ... service delivery and introduces two new mechanisms ... DATATRAK Learning Center(TM) and the DATATRAK Learning ...

(Date:12/16/2009)... AVAX Technologies, Inc. (Pink Sheets: AVXT) ("AVAX" or ... a bridge loan financing (the "2009 Financing") pursuant ... (the "Agreement") with Firebird Global Master Fund, Ltd., ... a convertible promissory note, due June 30, 2010, ... issued a warrant to purchase an aggregate of ...

(Date:12/16/2009)... RealMed has been ranked the ... 2009 Top 20 Best in KLAS ... RealMed is a dynamic revenue cycle management ... between healthcare providers and all ... specializing in vendor performance measurement in the ...

Breaking Medicine Technology:DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2 DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3 DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4 AVAX Technologies, Inc. Closes Bridge Financing 2 AVAX Technologies, Inc. Closes Bridge Financing 3 AVAX Technologies, Inc. Closes Bridge Financing 4 RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 2 RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 3 Is hepatic differentiation of embryonic stem cells induced by valproic acid and cytokines 3F 61615 1 No muss no fuss miniaturized analysis for complex samples developed 10786 1 No muss no fuss miniaturized analysis for complex samples developed 10786 2 No muss no fuss miniaturized analysis for complex samples developed 10786 3 Extinct moa rewrites New Zealands history 10782 1 Extinct moa rewrites New Zealands history 10782 2

[0] DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM)[0] AVAX Technologies, Inc. Closes Bridge Financing [0] RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service

... high eradication rates for the most common, ... REINACH, Switzerland, Oct. 26 Arpida ... two pivotal Phase III,clinical trials at the ... (ICAAC)/Infectious Diseases Society of America (IDSA) 46th,annual ...

... at ICAAC -, BRIDGEWATER, N.J., Oct. 26 ... 3, randomized, open-label, ongoing clinical,trial showed that 79 ... mg (two 400 mg tablets) with 100 mg ... (<50 copies/mL) at week 96,compared with 71 percent ...

Other Medicine Technology:Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 2 Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 3 Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 4 Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 5 Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 6 Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 7 Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 2 Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 3 Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 4 Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 5 Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 6 Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 7 Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 8

Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults

(Date:12/16/2009)... 16 New Enterprise Associates, Inc. (NEA), ... that one of its portfolio companies, Acclarent, Inc., ... acquired by Ethicon, Inc., a Johnson & Johnson ... million (net of estimated cash on hand at ... to designing, developing and commercializing devices that address ...

(Date:12/16/2009)... Immucor, Inc. (Nasdaq: BLUD ), a ... blood transfusion industry, today announced that Paul D. Mintz, ... new independent director, effective January 1, 2010. ,, ... transfusion medicine for more than 30 years. He is ... University of Virginia School of Medicine. He also serves ...

(Date:12/16/2009)... -- For wounded U.S. servicemen and women ... D.C., the holidays can be a particularly difficult time. ... rely more than ever on the healing power of ... home just got easier for Walter Reed patients as ... will provide hundreds of minutes of holiday talk time ...

(Date:12/16/2009)... CHICAGO, Dec. 16 HealthSciences Institute ... health care professionals, teams and organizations who ... by, chronic diseases in employer, health plan, ... The collaborative will offer free, noncommercial webinars ... chronic disease prevention, management and care improvement. ...

(Date:12/16/2009)... role in reducing inflammation in the lungs , , WEDNESDAY, ... plays a role in inflammation seems to protect the ... who smoke. , Researchers also found that adult smokers ... lower risk of developing chronic obstructive pulmonary disease (COPD), ... "The gene seems to be protective of the lungs ...

Breaking Medicine News(10 mins):Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 2 Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 3 Health News:Immucor Appoints New Board Director 2 Health News:Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital 2 Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2 Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3 Health News:Gene Variant Seems to Guard Against Asthma, COPD 2 Health News:Gene Variant Seems to Guard Against Asthma, COPD 3

[0] NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon [1] Immucor Appoints New Board Director [0] Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital [1] New Learning Collaborative to Prepare Clinicians for Better Chronic Care [0] Gene Variant Seems to Guard Against Asthma, COPD

... among the who,s who of asbestos litigators to assemble ... litigation trends and review what transpired in 2008.Shepard Hoffman, ... will be among a panel of litigators discussing new ... & Greenstone and Robert Thackston of Hawkins, Parnell & ...

... a Use Not Approved By the Food and Drug ... in two whistleblower suits filed in the Northern District ... its parent company, Johnson & Johnson Inc., alleging that ... use not approved by the Food and Drug Administration ...

... Association and nation,s largest animal protection group say taxing ... for pet owners, increased pet abandonment and public health ... California Veterinary Medical Association (CVMA) and The Humane Society ... the California Legislature for responding to the public,s opposition ...

... Corporation (NYSE: TMK ) announced today that ... Officer, Gary Coleman, will present Tuesday, February 24, 2009 ... York City. Torchmark,s presentation is scheduled to begin ... live at: www.torchmarkcorp.com , on the Investor Relations ...

... Feb. 19 California attorneys and a,presiding judge are ... will assemble next month in Los Angeles to discuss ... Robert Berkes of Berkes Crane ... perspective on asbestos litigation; Steven Kazan of Kazan McClain,Abrams ...

... quiet day at the office, and quite ordinary if you ... throughout the day. Travel Advantage Network employees paid $1 toward ... for the day. Any silenced employees could buy back their ... day raised more than $100 toward the month,s total of ...

Other Medicine News:Health News:Dallas Attorneys Featured at Major Asbestos Litigation Event 2 Health News:United States Joins Suits Against Scios and Johnson & Johnson 2 Health News:United States Joins Suits Against Scios and Johnson & Johnson 3 Health News:Pet Owners Avoid a Tax on Their Pet's Health Care in California's Budget 2 Health News:Pet Owners Avoid a Tax on Their Pet's Health Care in California's Budget 3 Health News:California Attorneys Featured at Major Asbestos Litigation Event 2 Health News:Travel Advantage Network Enjoys Silencing Co-Workers, Raising More Than $1,600 for Autism 2

Dallas Attorneys Featured at Major Asbestos Litigation Event United States Joins Suits Against Scios and Johnson & Johnson Pet Owners Avoid a Tax on Their Pet's Health Care in California's Budget Torchmark Corporation to Present at Merrill Lynch Insurance Investors Conference California Attorneys Featured at Major Asbestos Litigation Event Travel Advantage Network Enjoys Silencing Co-Workers, Raising More Than $1,600 for Autism

For the quantitative determination of direct & total bilirubin in serum. Modified Malloy-Evelyn Diazotization Method. Endpoint Reaction Product measured at 540 nm. Linearity: 20 mg/dl...

... first microplate spectrophotometer designed specifically to run ... week. With rugged hardware, proven optical performance ... barrier of traditional spectrophotometry to obtain results ... easily read up to eight, 1 cm ...

... The 1100RS Spectrophotometers ... economical. Great for use ... laboratories, including educational, clinical, ... Options include COD vial ...

Spectra 3000RS & Spectra 3000RSP are very precise instruments. They have a metal base structure, durable parts for long life use, and they are very easy to use and maintain....

Medicine Products:

Bilirubin, Direct & Total RPRWI/96 Spectrophotometers Spectrophotometers 1100RS Spectra 3000, 110V/60Hz

Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermat...(ta Incorporated Tara Spiess TS Com...),Health